Результати пошуку - F. Forconi

P650: A FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-5948, AN ORAL BTK DEGRADER, IN PATIENTS WITH RELAPSED AND REFRACTORY B-CELL MALIGNANCIES за авторством K. Linton, G. P. Collins, D. El-Sharkawi, R. Mous, F. Forconi, M. Tan, S. Nandakumar, E. Meredith, K. L. Jameson, S. G. Injac, J. Doorduijn

Отримати повний текст

C040 | BEXOBRUTIDEG (NX-5948), A NOVEL BRUTON’S TYROSINE KINASE DEGRADER, DEMONSTRATES RAPID AND DURABLE CLINICAL RESPONSES IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA UPDA... за авторством P. Zinzani, Z. Omer, A. Danilov, F. Forconi, N. Shah, G. Collins, S. Ma, J. Robertson, A. Alencar, D. Brander, J. Byrd, D. El-Sharkawi, J. Smith, A. Winter, M. Kwiatek, J. Cohen, P. Islam, S. Injac, T. Munir

Отримати повний текст

P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY за авторством R. Owen, H. McCarthy, S. Rule, S. D’Sa, S. Thomas, O. Tournilhac, F. Forconi, M. José Kersten, P. Luigi Zinzani, S. Iyengar, J. Kothari, M. Minnema, E. Kastritis, B. Cheson, H. Walter, D. Greewald, R. Calvo, C.-C. Wun, R. Furman

Отримати повний текст

S145: THE COMBINATION OF IBRUTINIB PLUS VENETOCLAX RESULTS IN A HIGH RATE OF MRD NEGATIVITY IN PREVIOUSLY UNTREATED CLL: THE RESULTS OF THE PLANNED INTERIM ANALYSIS OF THE PHASE II... за авторством P. Hillmen, A. Pitchford, A. Bloor, A. Pettitt, P. Patten, F. Forconi, A. Schuh, C. Fox, N. Elmusharaf, S. Gatto, B. Kennedy, J. Gribben, N. Pemberton, O. Sheehy, G. Preston, D. Howard, A. Hockaday, D. Cairns, S. Jackson, N. Greatorex, N. Webster, S. Dalal, J. Shingles, K. Cwynarski, S. Paneesha, D. Allsup, A. Rawstron, T. Munir

Отримати повний текст